Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0591-3331
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0591-3331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bupropion Hydrochloride Er Tablets (Image 2)
This is a medication guide for BuPROPion Hydrochloride Extended-Release Tablets (XL) with a warning not to use in combination with ZYBAN® or any other medicines containing bupropion hydrochloride. The tablets contain 150mg of the active ingredient and should be taken daily as directed by a physician. It is manufactured by Teva Pharmaceuticals and comes in a bottle of 30 tablets. The lot number and expiration date are printed on the label. Printed medication guides are available on tevausa.com/medguides.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.